NTRK2 and depressive disorder: This finding is of particular interest because changes in Bdnf-TrkB signaling have been implicated in both the etiology of depression and antidepressant drug action15, and co-treatment of IMS Balb/c mice with fluoxetine and the TrkB receptor blocker Ana-12 did indeed abolish the effects of fluoxetine on emotional behavior.